Coiled Therapeutics annual free cash flow
2022
2023
2024
Coiled Therapeutics Free Cash Flow (FCF) History (COIL)
Coiled Therapeutics reported −£783,731 in free cash flow for fiscal 2024, an increase of £1.0M from the previous fiscal year.
View full Coiled Therapeutics company overviewCoiled Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −£783,731 | £1.0M | — | — |
| 2023 | 2023-12-31 | −£1.8M | −£210,099 | — | −893.79% |
| 2022 | 2022-12-31 | −£1.6M | — | — | — |
Coiled Therapeutics free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Coiled Therapeutics source filings ↗Community posts
Coiled reports £3.85 million interim loss after oncology transformation
Coiled Therapeutics ($COIL) reported a first-half loss before tax of £3.85 million, compared with £0.53 million a year earlier, following its shift into clinical-stage oncology. Operating activities consumed £2.85 million of cash versus £0. ...
